Our Services
Medical Information
Helpful Resources
Published on: 6/15/2026
Polymyalgia rheumatica (PMR) is an inflammatory condition that causes rapid-onset stiffness and pain in the shoulders and hips, primarily affecting adults over age 50. Early diagnosis is critical because PMR responds well to low-dose corticosteroids and requires prompt evaluation to rule out giant cell arteritis—a serious complication that can cause permanent vision loss—as well as to distinguish it from similar conditions like rheumatoid arthritis, fibromyalgia, and hypothyroidism.
Key signs include morning stiffness lasting more than 45 minutes, bilateral aching in the neck, shoulders, or hips, low-grade fever, fatigue, and unintended weight loss. Diagnosis typically involves blood tests (ESR and CRP) to confirm inflammation, alongside a thorough clinical evaluation.
Because PMR symptoms overlap with many other conditions—and because delayed treatment can lead to serious complications—it's essential to identify what's driving your symptoms quickly. Take a free, instant, online symptom check to better understand your symptoms and confidently navigate your next steps with a clearer picture in hand.
Reviewed for medical accuracy: 06/15/2026
Polymyalgia rheumatica (PMR) is an inflammatory condition that primarily affects adults over 50, causing painful stiffness in the shoulders, hips, and neck. Early testing and diagnosis are crucial to ease symptoms quickly, prevent complications, and rule out other serious diseases.
Shoulder Stiffness and Pain
Hip and Thigh Discomfort
Neck, Upper Arms, and Lower Back
Systemic Signs
Speedy Symptom Relief
Preventing Complications
Ruling Out Other Conditions
Monitoring Disease Activity
Your healthcare provider may suggest:
Medical History & Physical Exam
Blood Tests
Ultrasound or MRI (in select cases)
Temporal Artery Evaluation (if GCA is suspected)
Low-Dose Corticosteroids
Calcium and Vitamin D
Physical Activity
Regular Monitoring
If you're experiencing persistent or worsening shoulder and hip stiffness—especially if it's affecting daily tasks—consider early evaluation. You might also:
Important: This information is not a substitute for medical advice. If you experience severe, life-threatening, or persistent symptoms, please speak to a doctor as soon as possible.
(References)
* Dejaco C, et al. 2023 EULAR/ACR classification criteria for polymyalgia rheumatica. Ann Rheum Dis. 2023;82(11):1428-1436. doi:10.1136/ard-2023-224424.
* Loricera J, et al. Polymyalgia Rheumatica: An Update on the Diagnosis, Treatment, and Management of Special Situations. Front Med (Lausanne). 2022;9:945207. doi:10.3389/fmed.2022.945207.
* Barraclough K, et al. Polymyalgia rheumatica in primary care: diagnostic challenges and a role for imaging. Br J Gen Pract. 2021;71(706):227-228. doi:10.3399/bjgp21X715105.
* Mackie SL, et al. Polymyalgia rheumatica. Best Pract Res Clin Rheumatol. 2018;32(1):2-13. doi:10.1016/j.berh.2018.03.003.
* Dasgupta B, et al. 2012 EULAR/ACR recommendations for the management of polymyalgia rheumatica. Ann Rheum Dis. 2015;74(10):1781-1789. doi:10.1136/annrheumdis-2014-206892.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.